PTK2B and Alzheimer disease: Thus, Pyk2 activity exhibits divergent effects on Aβ versus Tau driven toxicity in AD mouse models; on the one hand contributing to toxic Aβ signaling and, on the other, protecting against Tau phosphorylation and related pathology.